electroCore, Inc. (ECOR) |
|
4.55 -0.14 (-2.99%)
|
06-06 15:59 |
|
Open: |
4.65 |
Pre. Close: |
4.69 |
|
High:
|
4.7115 |
Low:
|
4.53 |
|
Volume:
|
14,703 |
Market Cap:
|
22(M) |
|
|
|
Technical analysis |
as of: 2023-06-06 4:27:23 PM |
|
Short-term rate:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 6.85 One year: 7.83 |
| Support: |
Support1: 4.5 Support2: 3.74 |
| Resistance: |
Resistance1: 5.86 Resistance2: 6.71 |
| Pivot: |
5.34  |
| Moving Average: |
MA(5): 4.69 MA(20): 5.56
MA(100): 5.14 MA(250): 6 |
| MACD: |
MACD(12,26): -0.4 Signal(9): -0.3 |
| Stochastic oscillator: |
%K(14,3): 3.8 %D(3): 4.4 |
| RSI: |
RSI(14): 31.6 |
| 52-week: |
High: 10.5 Low: 2.92 |
| Average Vol(K): |
3-Month: 23 (K) 10-Days: 16 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ECOR ] has closed above bottom band by 15.6%. Bollinger Bands are 17.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.72 - 4.75 |
4.75 - 4.78 |
|
Low:
|
4.45 - 4.49 |
4.49 - 4.53 |
|
Close:
|
4.49 - 4.55 |
4.55 - 4.61 |
|
Company Description |
|
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey. |
Headline News |
Fri, 26 May 2023
electroCore (ECOR) Announces Departure of JP Errico from Board - StreetInsider.com
Tue, 23 May 2023
ElectroCore to Participate at 13th Annual LD Micro Invitational XIII - Marketscreener.com
Thu, 04 May 2023
HC Wainwright & Co. Maintains ElectroCore (ECOR) Buy ... - Nasdaq
Wed, 19 Apr 2023
electroCore to Announce First Quarter Financial Results on Wednesday, May 3 - Yahoo Finance
Wed, 19 Apr 2023
CG Capital Reiterates ElectroCore (ECOR) Outperform ... - Nasdaq
Wed, 12 Apr 2023
electroCore Expands Intellectual Patent Portfolio for nVNS Technology - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
5 (M) |
| Shares Float |
4 (M) |
|
% Held by Insiders
|
17.4 (%) |
|
% Held by Institutions
|
17.2 (%) |
|
Shares Short
|
85 (K) |
|
Shares Short P.Month
|
83 (K) |
Stock Financials |
|
EPS
|
-4.5 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
2.5 |
|
Profit Margin (%)
|
-237 |
|
Operating Margin (%)
|
-245.5 |
|
Return on Assets (ttm)
|
-52.4 |
|
Return on Equity (ttm)
|
-102.9 |
|
Qtrly Rev. Growth
|
46.4 |
|
Gross Profit (p.s.)
|
1.51 |
|
Sales Per Share
|
1.99 |
|
EBITDA (p.s.)
|
-4.78 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-18 (M) |
|
Levered Free Cash Flow
|
-11 (M) |
Stock Valuations |
|
PE Ratio
|
-1.02 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
1.82 |
|
Price to Sales
|
2.28 |
|
Price to Cash Flow
|
-1.22 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
